Back Cover: Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity (ChemMedChem 1/2017)
The back cover picture shows how the branched cell‐penetrating peptide (CPP), namely (sC18)2, effectively enters cancerous cells. Owing to its structural properties, different interactions between cancerous and noncancerous cells occur, leading to obvious different entry pathways. As a result, (sC18...
Gespeichert in:
| Veröffentlicht in: | ChemMedChem 2017-01, Vol.12 (1), p.104-104 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 104 |
|---|---|
| container_issue | 1 |
| container_start_page | 104 |
| container_title | ChemMedChem |
| container_volume | 12 |
| creator | Gronewold, Anja Horn, Mareike Ranđelović, Ivan Tóvári, József Muñoz Vázquez, Sergio Schomäcker, Klaus Neundorf, Ines |
| description | The back cover picture shows how the branched cell‐penetrating peptide (CPP), namely (sC18)2, effectively enters cancerous cells. Owing to its structural properties, different interactions between cancerous and noncancerous cells occur, leading to obvious different entry pathways. As a result, (sC18)2 strongly affects cancerous cells and exhibits significant toxic activity to a wide range of different cancer cell types. Moreover, synergistic effects were obtained when combining the CPP with the cytostatic drug actinomycin D. More information can be found in the Full Paper by Ines Neundorf et al. on page 42 in Issue 1, 2017 (DOI:10.1002/cmdc.201600498). |
| doi_str_mv | 10.1002/cmdc.201600624 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1856770509</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4297059891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1574-c7af974b1cef11feb878656190ef4eebd1832717dc1ff665499d82c272b273db3</originalsourceid><addsrcrecordid>eNqFkL1OwzAUhSMEEqWwMltigSGt7Sa2w1bMr0RFB5gtx7mmLmlSHLdVmXgEnpEnIVVRGZnO1dV37s-JolOCewRj2jezwvQoJgxjRpO9qEMEwzEngu_vap4dRkdNM8U4SQQRnShcafOGZL0Ef4nkRHttAnj3oYOrK1RbpJGEsvz-_BpDBcG3_eoVjWEeXAFo5cIEjesAVXC6RMNWjK4MeDQ0wS1dWKNzOYHZCIqNINJv7-MXx9GB1WUDJ7_ajV5ub57lffz4dPcgh4-xISlPYsO1zXiSEwOWEAu54IKljGQYbAKQF0QMaPtTYYi1jKVJlhWCGsppTvmgyAfd6Gw7d-7r9wU0QU3rha_alYqIlHGOU5y1VG9LGV83jQer5t7NtF8rgtUmWbVJVu2SbQ3Z1rByJaz_oZUcXcs_7w97qH0a</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1856770509</pqid></control><display><type>article</type><title>Back Cover: Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity (ChemMedChem 1/2017)</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gronewold, Anja ; Horn, Mareike ; Ranđelović, Ivan ; Tóvári, József ; Muñoz Vázquez, Sergio ; Schomäcker, Klaus ; Neundorf, Ines</creator><creatorcontrib>Gronewold, Anja ; Horn, Mareike ; Ranđelović, Ivan ; Tóvári, József ; Muñoz Vázquez, Sergio ; Schomäcker, Klaus ; Neundorf, Ines</creatorcontrib><description>The back cover picture shows how the branched cell‐penetrating peptide (CPP), namely (sC18)2, effectively enters cancerous cells. Owing to its structural properties, different interactions between cancerous and noncancerous cells occur, leading to obvious different entry pathways. As a result, (sC18)2 strongly affects cancerous cells and exhibits significant toxic activity to a wide range of different cancer cell types. Moreover, synergistic effects were obtained when combining the CPP with the cytostatic drug actinomycin D. More information can be found in the Full Paper by Ines Neundorf et al. on page 42 in Issue 1, 2017 (DOI:10.1002/cmdc.201600498).</description><identifier>ISSN: 1860-7179</identifier><identifier>EISSN: 1860-7187</identifier><identifier>DOI: 10.1002/cmdc.201600624</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>anticancer activity ; cell-penetrating peptides ; lytic peptides ; tumor cells ; tumor targeting</subject><ispartof>ChemMedChem, 2017-01, Vol.12 (1), p.104-104</ispartof><rights>2017 Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcmdc.201600624$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcmdc.201600624$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Gronewold, Anja</creatorcontrib><creatorcontrib>Horn, Mareike</creatorcontrib><creatorcontrib>Ranđelović, Ivan</creatorcontrib><creatorcontrib>Tóvári, József</creatorcontrib><creatorcontrib>Muñoz Vázquez, Sergio</creatorcontrib><creatorcontrib>Schomäcker, Klaus</creatorcontrib><creatorcontrib>Neundorf, Ines</creatorcontrib><title>Back Cover: Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity (ChemMedChem 1/2017)</title><title>ChemMedChem</title><description>The back cover picture shows how the branched cell‐penetrating peptide (CPP), namely (sC18)2, effectively enters cancerous cells. Owing to its structural properties, different interactions between cancerous and noncancerous cells occur, leading to obvious different entry pathways. As a result, (sC18)2 strongly affects cancerous cells and exhibits significant toxic activity to a wide range of different cancer cell types. Moreover, synergistic effects were obtained when combining the CPP with the cytostatic drug actinomycin D. More information can be found in the Full Paper by Ines Neundorf et al. on page 42 in Issue 1, 2017 (DOI:10.1002/cmdc.201600498).</description><subject>anticancer activity</subject><subject>cell-penetrating peptides</subject><subject>lytic peptides</subject><subject>tumor cells</subject><subject>tumor targeting</subject><issn>1860-7179</issn><issn>1860-7187</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkL1OwzAUhSMEEqWwMltigSGt7Sa2w1bMr0RFB5gtx7mmLmlSHLdVmXgEnpEnIVVRGZnO1dV37s-JolOCewRj2jezwvQoJgxjRpO9qEMEwzEngu_vap4dRkdNM8U4SQQRnShcafOGZL0Ef4nkRHttAnj3oYOrK1RbpJGEsvz-_BpDBcG3_eoVjWEeXAFo5cIEjesAVXC6RMNWjK4MeDQ0wS1dWKNzOYHZCIqNINJv7-MXx9GB1WUDJ7_ajV5ub57lffz4dPcgh4-xISlPYsO1zXiSEwOWEAu54IKljGQYbAKQF0QMaPtTYYi1jKVJlhWCGsppTvmgyAfd6Gw7d-7r9wU0QU3rha_alYqIlHGOU5y1VG9LGV83jQer5t7NtF8rgtUmWbVJVu2SbQ3Z1rByJaz_oZUcXcs_7w97qH0a</recordid><startdate>20170105</startdate><enddate>20170105</enddate><creator>Gronewold, Anja</creator><creator>Horn, Mareike</creator><creator>Ranđelović, Ivan</creator><creator>Tóvári, József</creator><creator>Muñoz Vázquez, Sergio</creator><creator>Schomäcker, Klaus</creator><creator>Neundorf, Ines</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20170105</creationdate><title>Back Cover: Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity (ChemMedChem 1/2017)</title><author>Gronewold, Anja ; Horn, Mareike ; Ranđelović, Ivan ; Tóvári, József ; Muñoz Vázquez, Sergio ; Schomäcker, Klaus ; Neundorf, Ines</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1574-c7af974b1cef11feb878656190ef4eebd1832717dc1ff665499d82c272b273db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>anticancer activity</topic><topic>cell-penetrating peptides</topic><topic>lytic peptides</topic><topic>tumor cells</topic><topic>tumor targeting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gronewold, Anja</creatorcontrib><creatorcontrib>Horn, Mareike</creatorcontrib><creatorcontrib>Ranđelović, Ivan</creatorcontrib><creatorcontrib>Tóvári, József</creatorcontrib><creatorcontrib>Muñoz Vázquez, Sergio</creatorcontrib><creatorcontrib>Schomäcker, Klaus</creatorcontrib><creatorcontrib>Neundorf, Ines</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>ChemMedChem</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gronewold, Anja</au><au>Horn, Mareike</au><au>Ranđelović, Ivan</au><au>Tóvári, József</au><au>Muñoz Vázquez, Sergio</au><au>Schomäcker, Klaus</au><au>Neundorf, Ines</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Back Cover: Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity (ChemMedChem 1/2017)</atitle><jtitle>ChemMedChem</jtitle><date>2017-01-05</date><risdate>2017</risdate><volume>12</volume><issue>1</issue><spage>104</spage><epage>104</epage><pages>104-104</pages><issn>1860-7179</issn><eissn>1860-7187</eissn><abstract>The back cover picture shows how the branched cell‐penetrating peptide (CPP), namely (sC18)2, effectively enters cancerous cells. Owing to its structural properties, different interactions between cancerous and noncancerous cells occur, leading to obvious different entry pathways. As a result, (sC18)2 strongly affects cancerous cells and exhibits significant toxic activity to a wide range of different cancer cell types. Moreover, synergistic effects were obtained when combining the CPP with the cytostatic drug actinomycin D. More information can be found in the Full Paper by Ines Neundorf et al. on page 42 in Issue 1, 2017 (DOI:10.1002/cmdc.201600498).</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/cmdc.201600624</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1860-7179 |
| ispartof | ChemMedChem, 2017-01, Vol.12 (1), p.104-104 |
| issn | 1860-7179 1860-7187 |
| language | eng |
| recordid | cdi_proquest_journals_1856770509 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | anticancer activity cell-penetrating peptides lytic peptides tumor cells tumor targeting |
| title | Back Cover: Characterization of a Cell‐Penetrating Peptide with Potential Anticancer Activity (ChemMedChem 1/2017) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A16%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Back%20Cover:%20Characterization%20of%20a%20Cell%E2%80%90Penetrating%20Peptide%20with%20Potential%20Anticancer%20Activity%20(ChemMedChem%201/2017)&rft.jtitle=ChemMedChem&rft.au=Gronewold,%20Anja&rft.date=2017-01-05&rft.volume=12&rft.issue=1&rft.spage=104&rft.epage=104&rft.pages=104-104&rft.issn=1860-7179&rft.eissn=1860-7187&rft_id=info:doi/10.1002/cmdc.201600624&rft_dat=%3Cproquest_cross%3E4297059891%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1856770509&rft_id=info:pmid/&rfr_iscdi=true |